Mereo BioPharma Group plc
MREO
$0.24
$0.00-1.83%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -15.82% | -13.23% | -10.18% | -10.49% | -13.31% |
| Total Receivables | 29.19% | -59.03% | 56.26% | -26.22% | 14.32% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -26.20% | -54.75% | -29.98% | 506.67% | -90.76% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 0.42% | 311.69% | 5.79% | -73.63% | 229.75% |
| Total Current Assets | -14.10% | -14.68% | -8.19% | -10.52% | -13.79% |
|
|
|||||
| Total Current Assets | -14.10% | -14.68% | -8.19% | -10.52% | -13.79% |
| Net Property, Plant & Equipment | -30.98% | -25.41% | -14.84% | -11.69% | -19.61% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -19.75% | 36.81% | -15.16% | -13.84% | -19.52% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -14.34% | -14.42% | -8.33% | -10.56% | -13.92% |
|
|
|||||
| Total Accounts Payable | 46.76% | -21.02% | -61.02% | 18.17% | 34.90% |
| Total Accrued Expenses | -45.81% | -18.89% | 65.90% | -29.67% | -18.03% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -49.12% | -33.94% | -19.54% | -88.03% | -0.72% |
| Total Finance Division Other Current Liabilities | 2.84% | -18.09% | 4.03% | 4.20% | -0.28% |
| Total Other Current Liabilities | 2.84% | -18.09% | 4.03% | 4.20% | -0.28% |
| Total Current Liabilities | -28.49% | -20.39% | 0.80% | -45.86% | -2.53% |
|
|
|||||
| Total Current Liabilities | -28.49% | -20.39% | 0.80% | -45.86% | -2.53% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -52.54% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -29.25% | 10.14% | 20.56% | -46.32% | -13.81% |
| Total Liabilities | -28.60% | -17.15% | 2.58% | -46.56% | -4.87% |
|
|
|||||
| Common Stock & APIC | 0.29% | 0.31% | 0.38% | 0.87% | 0.60% |
| Retained Earnings | -1.49% | -1.44% | -3.10% | -1.98% | -1.55% |
| Treasury Stock & Other | 0.80% | -26.23% | 43.47% | 18.88% | -69.75% |
| Total Common Equity | -12.19% | -13.99% | -9.83% | -1.46% | -15.95% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -12.19% | -13.99% | -9.83% | -1.46% | -15.95% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -12.19% | -13.99% | -9.83% | -1.46% | -15.95% |
|
|
|||||